Back to Search Start Over

Clinical Features and HSCT Outcome for SCID in Turkey

Authors :
Atilla Halil Elhan
Ilhan Tezcan
Aydan Ikinciogullari
Savaş Kansoy
Gulsum Karasu
Orhan Gürsel
Sule Haskologlu
Vedat Uygun
Alphan Kupesiz
Figen Dogu
Deniz Cagdas
Can Ateş
Tuba Tugrul
Alisan Yildiran
Akif Yeşilipek
Serap Aksoylar
Ondokuz Mayıs Üniversitesi
Source :
Journal of clinical immunology. 39(3)
Publication Year :
2018

Abstract

Elhan, Atilla Halil/0000-0003-3324-248X; Ikinciogullari, Aydan/0000-0003-1145-0843; Dogu, Figen/0000-0002-7869-4941; ates, can/0000-0003-2286-4398 WOS: 000468974100018 PubMed: 30924026 Severe combined immunodeficiency (SCID) is the most serious PID, characterized by T cell lymphopenia and lack of antigen-specific T cell and B cell immune responses, inevitably leading to death within the first year of life if hematopoietic stem cell transplantation (HSCT) is not performed. Purpose and Methods Since SCID is a common type of PID with an estimated incidence of 1/10.000 in Turkey, a retrospective analysis of HSCT characteristics, survival, immune recovery, and the major clinical features of SCID prior to HSCT is the aim of this multi-transplant center-based analysis. Results A total of 234 SCID patients transplanted between the years 1994 and 2014 were included in the study. Median age at diagnosis was 5 months, at transplantation, 7 months, B- phenotype and RAGs were the most common defects among others. Immune phenotype did not seem to have an effect on survival rate (p > 0.05), Immunoglobulin (Ig) requirement following HSCT did not differ between B+ and B- phenotypes (p > 0.05). Overall survival rate was 65.7% over a period of 20 years. It increased from 54% (1994-2004) to 69% (p = 0.052) during the last 10 years (2005-2014). Ten-year survival after HSCT has improved over time although the difference was not significant. Infection at the time of transplantation (p = 0.006), mismatched related donor (MMRD) (haploidentical parents), and matched unrelated donor (MUD) donor transplants p < 0.001 were the most important factors, significantly affecting the outcome. Conclusions This is the first multicenter study with the largest data obtained from transplanted SCID patients in Turkey. Early diagnosis with newborn screening (NBS) together with emerging referrals, treatment by transplantation centers, and specialized teams are mandatory in countries with high parental consanguinity such as Turkey.

Details

ISSN :
15732592
Volume :
39
Issue :
3
Database :
OpenAIRE
Journal :
Journal of clinical immunology
Accession number :
edsair.doi.dedup.....945f5aab2e2ec55937401736e71cde39